These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
695 related items for PubMed ID: 30828331
41. T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs. de Melo AB, Nascimento EJ, Braga-Neto U, Dhalia R, Silva AM, Oelke M, Schneck JP, Sidney J, Sette A, Montenegro SM, Marques ET. PLoS Negl Trop Dis; 2013; 7(1):e1938. PubMed ID: 23383350 [Abstract] [Full Text] [Related]
42. Components of protective immunity. Zhang G, Zhang Y, Samuel JE. Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628 [Abstract] [Full Text] [Related]
49. The Feasibility of Using Coxiella burnetii Avirulent Nine Mile Phase II Viable Bacteria as a Live Attenuated Vaccine Against Q fever. Kumaresan V, Alam S, Zhang Y, Zhang G. Front Immunol; 2021; 12():754690. PubMed ID: 34795669 [Abstract] [Full Text] [Related]
50. Intact interferon-γ response against Coxiella burnetii by peripheral blood mononuclear cells in chronic Q fever. Schoffelen T, Textoris J, Bleeker-Rovers CP, Ben Amara A, van der Meer JW, Netea MG, Mege JL, van Deuren M, van de Vosse E. Clin Microbiol Infect; 2017 Mar; 23(3):209.e9-209.e15. PubMed ID: 27876593 [Abstract] [Full Text] [Related]
53. Unveiling promising immunogenic targets in Coxiella burnetii through in silico analysis: paving the way for novel vaccine strategies. Kodori M, Amani J, Ahmadi A. BMC Infect Dis; 2023 Dec 21; 23(1):902. PubMed ID: 38129801 [Abstract] [Full Text] [Related]
54. Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria. Ganeshan H, Kusi KA, Anum D, Hollingdale MR, Peters B, Kim Y, Tetteh JK, Ofori MF, Gyan BA, Koram KA, Huang J, Belmonte M, Banania JG, Dodoo D, Villasante E, Sedegah M. Malar J; 2016 Feb 01; 15():55. PubMed ID: 26830334 [Abstract] [Full Text] [Related]
56. Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii. Waag DM, England MJ, Bolt CR, Williams JC. Clin Vaccine Immunol; 2008 Oct 01; 15(10):1505-12. PubMed ID: 18701647 [Abstract] [Full Text] [Related]
57. Developing a new clinical tool for diagnosing chronic Q fever: the Coxiella ELISPOT. Limonard GJ, Thijsen SF, Bossink AW, Asscheman A, Bouwman JJ. FEMS Immunol Med Microbiol; 2012 Feb 01; 64(1):57-60. PubMed ID: 22067057 [Abstract] [Full Text] [Related]